P21
P21 (CNTF-derived peptide)
Overview
P21 is a synthetic peptide derived from the ciliary neurotrophic factor (CNTF) binding interface that has demonstrated potent neurogenic and cognitive enhancement properties in preclinical research. It is one of the most discussed emerging nootropic peptides in the research community due to reports of dramatic improvements in memory pattern recognition and cognitive function. P21 promotes neurogenesis in the hippocampus and has shown synergistic effects with Cerebrolysin in animal models. While human trial data is limited this peptide represents the frontier of neurogenic peptide research.
Where does P21 sit?
See how this peptide compares across all 70 peptides in our database.
Mechanism of Action
P21 acts by modulating the CNTF signaling pathway specifically targeting the gp130 and LIFRβ receptor complex that mediates CNTF's neurotrophic effects. By binding to the CNTF receptor interface P21 activates JAK-STAT signaling in neural stem cells promoting their proliferation and differentiation into neurons particularly in the hippocampal dentate gyrus — the primary site of adult neurogenesis. P21 also upregulates BDNF expression and reduces the activity of inhibitory factors that suppress neural stem cell division. The result is enhanced hippocampal neurogenesis which correlates with improvements in spatial memory pattern separation and cognitive flexibility in animal models. P21 appears to have a particularly strong effect on new neuron survival and integration into existing neural circuits.
Dosage Information
Typical Dose
100-300 mcg daily
Frequency
Once daily
Administration
Subcutaneous injection
Notes
Limited human data available. Often stacked with Cerebrolysin in research protocols. Cycles of 4-8 weeks typically used.
Potential Side Effects
Community Experiences
No experiences shared yet. Be the first!
Quick Facts
- Administration
- Subcutaneous injection
- Typical Dose
- 100-300 mcg daily
- Frequency
- Once daily
- References
- 0 curated + 0 from PubMed
- Evidence Score
- 8.0 / 100